This drug interferes with testosterone metabolism and is an alternative to the more commonly used Alpha-blockers in the treatment of Benign Prostatic Hyperplasia. Recent studies have shown that it has reduced the risk of needing surgery by 55%, reduced urinary flow obstruction and reduced one of the main problems which is urinary retention. The study suggests that it produced no serious adverse effects but impotence and decreased libido are more serious to some than others.